TerminatedEUCTR 2012-004132-33
Lurasidone for depression
This study was terminated in the United Kingdom. It is testing lurasidone for depression.
In United KingdomDepression, BipolarityOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedEUCTR 2008-001767-11
Slow Transitioning compared with Fast Transitioning from a Stimulant Medication to Atomoxetine for ADHD
This study is completed in the United Kingdom, in Spain, and in Portugal. It is testing slow Transitioning compared with Fast Transitioning from a Stimulant Medication to Atomoxetine for ADHD.
In United KingdomADHDOther
CompletedEUCTR 2006-005512-27
Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care for ADHD
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care for ADHD.
In United KingdomADHDOther
CompletedEUCTR 2014-004588-19
Safety study of efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Depression
This study is completed in the United Kingdom, in Belgium, in Sweden, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for Depression.
In United KingdomDepressionOther
TerminatedEUCTR 2008-001580-11
3 Doses of Lu AA21004 for depression
This study was terminated in France, in the United Kingdom, in Germany, .... It is testing 3 Doses of Lu AA21004 for depression.
In United KingdomDepressionOther
TerminatedEUCTR 2008-001766-90
Single Dose of Lu AA21004 for Anxiety
This study was terminated in the United Kingdom, in Germany, in Latvia, .... It is testing Single Dose of Lu AA21004 for Anxiety.
In United KingdomAnxietyOther
CompletedNCT03319953
Effects of TAK-041 on Motivational Anhedonia for schizophrenia
This study is completed in the United Kingdom. It is testing Effects of TAK-041 on Motivational Anhedonia for schizophrenia.
In United KingdomSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
TerminatedEUCTR 2017-001084-20
Effects of TAK-041 on Motivational Anhedonia for Schizophrenia
This study was terminated in the United Kingdom. It is testing Effects of TAK-041 on Motivational Anhedonia for Schizophrenia.
In United KingdomSchizophreniaOther
OngoingEUCTR 2020-001424-34
SAGE-217 for depression
This study is ongoing in the United Kingdom. It is testing SAGE-217 for depression.
In United KingdomDepressionOther
TerminatedEUCTR 2017-002232-16
TAK-653 for treatment-resistant depression
This study was terminated in the United Kingdom. It is testing TAK-653 for treatment-resistant depression.
In United KingdomDepressionOther
CompletedEUCTR 2012-000418-13
Safety and Efficacy of ABT-126 for schizophrenia
This study is completed in the United Kingdom. It is testing Safety and Efficacy of ABT-126 for schizophrenia.
In United KingdomSchizophreniaOther
TerminatedEUCTR 2012-005000-17
A proof of concept study effect of AFQ056 in OCD (OCD) patients resistant to Selective Seroton...
This study was terminated in the United Kingdom, in Germany, in Czechia, .... It is testing effect of AFQ056 for OCD.
In United KingdomOCDOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.